Microsoft Corp. has canceled some leases for US data center capacity, according to TD Cowen, raising broader concerns over whether it’s securing more AI computing capacity than it needs in the long term.

The move may reflect concerns about whether it’s building more AI computing than it will need over the long term, TD Cowen said in a report.

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team will present at the TD Cowen 45th Annual Health Care Conference on Monday,

A replay of the event will be available for 90 days and can be accessed by visiting the "Investor Calendar” section of the Vera Therapeutics website. Vera Therapeutics is a late clinical-stage biotechnology company focused on developing treatments for serious immunological diseases.